Michele Senni

Cardiovascular Department, Papa Giovanni XXIII Hospital, Bergamo, Italy

  • OrcidID
Read more

Media

2021 ESC Clinical Practice Recommendations on the use of SGLT-2 Inhibitors in Heart Failure: An Assessment of their Impact

Andrew JS Coats, Lars H Lund, Michele Senni, et al

James L Januzzi, Akshay S Desai, Andrew JS Coats, et al

COVID-19 Lessons Learnings From Italy

Michele Senni, Ankur Kalra,

COVID-19 Policies, Practices, and Outcomes in South Korea and Italy

Harriette Van Spall, Michele Senni, Duk-Woo Park, et al

John JV McMurray, Frank Ruschitzka, Michele Senni, et al

Articles by Michele Senni

Sodium–Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: Rationale for and Practical Use of a Successful Therapy

Mauro Gori, Emilia D’Elia, Edoardo Sciatti, et al

Published:

Citation: Cardiac Failure Review 2022;8:e26.

DOI:

https://doi.org/10.15420/cfr.2022.04
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction

Mauro Gori, James L Januzzi, Emilia D’Elia, et al

Published:

Citation: Cardiac Failure Review 2021;7:e06.

DOI:

https://doi.org/10.15420/cfr.2020.25
Treating Patients Following Hospitalisation for Acute Decompensated Heart Failure: An Insight into Reducing Early Rehospitalisations

Attilio Iacovoni, Emilia D’Elia, Mauro Gori, et al

Published:

Citation: Cardiac Failure Review 2019;5(2):78–82.

DOI:

https://doi.org/10.15420/cfr.2018.46.2
Haemodynamics of Heart Failure With Preserved Ejection Fraction: A Clinical Perspective

Mauro Gori, Attilio Iacovoni, Michele Senni, et al

Citation: Cardiac Failure Review 2016;2(2):102–5

DOI:

https://doi.org/10.15420/cfr.2016:17:2
Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart

Emilia D’Elia, Michele Senni,

Published:

Citation: Cardiac Failure Review 2020;6:e18.

DOI:

https://doi.org/10.15420/cfr.2020.11